From a quick reading, I think $ICOTF is rather peripheral to all of this stuff in the PR, mentioned only because they licensed a drug to Immune Pharma. I guess they don't have much to tell us at this time.
EDIT: Aha. The drug licensed from ICOTF is the one under development to treat this disease.
News 
Market Data 
Discover 
